UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 48

of 'Systemic therapy for advanced non-small cell lung cancer with an activating mutation in the epidermal growth factor receptor'

48
TI
CNS response to osimertinib in patients with T790M-positive advanced NSCLC: Data from a randomized phase III trial (AURA3)
AU
Mok T, Myung-Ju A, Han Ji-Youn, et al
SO
J Clin Oncol. 2017;35S: ASCO #9005
 
AD